LIONEX produces and supplies one of the largest numbers of mycobacterial antigens and monoclonal antibodies for research worldwide. A number of expression systems such as E. coli, insect cells, B.subtilis, Lactococcus lactis, M. smegmatis are available for initial screening followed by the selection of the most suitable system for high level expression and purification. FASTEST production of recombinant proteins: 1-2 mg of recombinant proteins within 4-6 weeks for pilot experiments. If required, we can scale up the production to gram quantities for customers.
LIONEX is developing novel Diagnostics for Tuberculosis and other diseases based on a series of proprietary platforms.
Our aim is to produce cost-effective, high-quality, rapid tests for endemic countries.
LIONEX is ISO13485 certified for IVD products, has state-of-the art infrastructure including molecular biology CAT-I, and CAT-II laboratories with access to CAT-III laboratories.
A number Lateral Flow Tests for In Vitro Diagnostics (IVD) of different indications are available at LIONEX.
LIONEX cooperates with big Pharma and large, international diagnostic companies for the development and production of their diagnostic tests.
A rare company which has developed and is producing ITS COVID-19 testS (Antigen as well as Antibody TeSTS (ELISA and POC rapid tests)), all in Braunschweig, GERMANY. NO OEM from China or S. Korea.
World's Leading Producer And Source Of TUBERCULOSIS/ Mycobacterial Antigens For Diagnostics And Vaccine Development
LIONEX is a German biotech company active in the fields of biomedicine and human health with special emphasis on TUBERCULOSIS (TB). Our focus is on research and In-Vitro-Diagnostic (IVD) product development for infectious diseases and cancer. LIONEX has recently launched a new IGRA (Interferon Gamma Release Assay) diagnostic test called LIOFeron®TB/LTBI for LTBI (Latent Tuberculosis Infection). It may also react positive in TB patients also but, as for other similar IGRA tests on the market, it cannot differentiate between LTBI and active TB.
LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.
LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.
Bovine tuberculosis tests are also available for research.
LIONEX has state of the manufacturing facilities for IVD-Lateral Flow Tests. All products are manufactured in Germany. All productions are done under ISO13485 certified conditions.
We are a highly reliable partner for OEM products for companies active in manufacturing and distribution of such products worldwide.
LIONEX partners and clients are large diagnostic companies, distributors, research institutions, universities, hospitals located on all continents.